Search

Your search keyword '"Fallara G"' showing total 197 results

Search Constraints

Start Over You searched for: Author "Fallara G" Remove constraint Author: "Fallara G" Journal european urology Remove constraint Journal: european urology
197 results on '"Fallara G"'

Search Results

1. Are reference intervals for free testosterone in healthy men reliable also in men with erectile dysfunction? Findings from a cross-sectional study

2. Intraoperative evaluation of surgical margins during robot-assisted radical prostatectomy: Comparison between fluorescence confocal microscopy and frozen section analysis with final pathology as standard reference

3. Revealing the disability and illness burden in infertile men: Key findings from a long-term longitudinal study utilizing the years lived with disability metric

4. A detailed analysis about perioperative complications, length of stay, readmission rates and treatment time after percutaneous thermal ablation for small renal masses

5. Unravelling familial ties: Elevated sperm DNA fragmentation index in infertile men and familial cancer susceptibility

6. Long-term comorbidity trends among men with primary infertility: findings from a long term comprehensive longitudinal study

7. Systematic review of clinical outcomes and step-by-step description of orthotopic bladder reconstruction following robot-assisted radical cystectomy

8. May assisted reproductive techniques outcomes impact on overall health parameters in infertile men?

9. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer

11. A0906 - Systematic review of clinical outcomes and step-by-step description of orthotopic bladder reconstruction following robot-assisted radical cystectomy

19. The effect of historical CMV infection on sperm parameters in white-European infertile men: Findings from a real-life cross-sectional study

20. Application of the KEYNOTE-564 trial results to real life population: Which patients with advanced kidney cancer should receive adjuvant pembrolizumab

21. The role of percutaneous renal tumor biopsy in frail patients with indeterminate small renal masses

22. Hyperestrogenism is associated with sexual function impairment in men – findings from a cross-sectional, real-life study

23. The learning curve of radical nephrectomy for kidney cancer: Implications for surgical training

24. Neglected lymph nodal metastases in patients with renal cancer: When to extend the anatomical template of lymph node dissection during nephrectomy

25. First-line treatment in advanced renal cell carcinoma: A quasi-individual patient data meta-analysis

26. Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery

27. Pancreatic metastases after surgery for renal cell carcinoma

28. Precision surgery for Von Hippel-Lindau renal cell carcinoma

29. The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort

30. Imaging intensity after surgery for clear cell renal cell carcinoma

31. Low birth weight is associated with sperm dna fragmentation and assisted reproductive technology outcomes in primary infertile men – results of a cross-sectional study

32. The impact of different WHO reference criteria for semen analysis in clinical practice: Who will benefit from the new 2021 cutoffs for normal sperm parameters?

34. Risks and benefits of partial nephrectomy with limited or without ischemia time

35. Oncologic outcomes in patients diagnosed with pT3a non-metastatic renal cell cancer according to renal vein thrombus or fat invasion

36. Predictors of phosphodiesterase type 5 Inhibitors (PDE5I)-discontinuation – Is a previous PDE5I-exposure at first clinical evaluation related with a higher PDE5I-drop-out risk?

37. The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma

38. Prostate volume is associated with optimal TRIFECTA outcomes after HoLEP – results from a prospective trial (ExpHo)

39. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma

41. Risk of orgasmic function impairment after HoLEP – findings of a prospective real-life trial (ExpHo)

43. Impact of urinary incontinence on sexual function in patients presenting for lower urinary tract symptoms

44. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma

45. Relevance of self-masturbation-related vs. coital erectile function in the real-life management of patients with erectile dysfunction

46. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma

47. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma

48. Oncologic surveillance for variant histology upper tract urothelial carcinoma

49. Clinical outcomes of patients with renal cell carcinoma and imperative indication to become anephric: Implications for multidisciplinary board evaluation

Catalog

Books, media, physical & digital resources